Max Chat
Share chart Dyne Therapeutics, Inc.
Extended chart
Simple chart
About Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc., компания, занимающаяся заболеваниями мышц, работает как биотехнологическая компания, которая занимается продвижением терапевтических средств для лечения генетически обусловленных заболеваний мышц в Соединенных Штатах. Он разрабатывает различные программы для миотонической дистрофии 1 типа, мышечной дистрофии Дюшенна и фациоскапуло-плечевой дистрофии, а также для лечения редких заболеваний скелетных мышц, сердечных и метаболических мышц, используя платформу FORCE, которая обеспечивает терапию, изменяющую заболевание. Компания была основана в 2017 году, ее штаб-квартира находится в Уолтеме, штат Массачусетс.
Main settings
IPO date
2020-09-17
ISIN
US26818M1080
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 0 | 0 |
| P/BV | 3.52 | 5 |
| P/E | 0 | 0 |
Efficiency
| Title | Value | Grade |
| ROA | -74.14 | 0 |
| ROE | -88.03 | 0 |
| ROIC | -36.69 | 0 |
Dividends
| Title | Value | Grade |
| Dividend yield | 0 | 0 |
| DSI | 0 | 0 |
| Average dividend growth | 0 | 0 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | -0.0761 | 10 |
| Debt/Ratio | 0.0347 | 10 |
| Debt/Equity | 0.0975 | 10 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | 16766.67 | 10 |
| Yield Ebitda, % | 437.84 | 10 |
| Yield EPS, % | -18.36 | 0 |
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 14.46 $ | 0 $ | 0 $ | -0.1383 % | 0 % | 0 % |
| Week | 14.7 $ | 0 $ | 0 $ | -1.77 % | 0 % | 0 % |
| Month | 11.9 $ | 14.44 $ | 14.44 $ | +21.34 % | 0 % | 0 % |
| Three month | 7.55 $ | 7.47 $ | 14.78 $ | +91.26 % | 0 % | 0 % |
| Half a year | 14.79 $ | 6.81 $ | 16.76 $ | -2.37 % | 0 % | 0 % |
| Year | 44.03 $ | 6.81 $ | 47.04 $ | -67.2 % | 0 % | 0 % |
| 3 years | 11.67 $ | 6.62 $ | 47.04 $ | +23.74 % | 0 % | 0 % |
| 5 years | 4.36 $ | 4.36 $ | 47.04 $ | +331.19 % | 0 % | 0 % |
| 10 years | 4.36 $ | 4.36 $ | 47.04 $ | +331.19 % | 0 % | 0 % |
| Year to date | 13.72 $ | 6.81 $ | 25.46 $ | +5.25 % | 0 % | 0 % |
Main owners
Contained in ETF
ETF | Share, % | Profitability for 1 year, % | Commission, % |
| Future Tech ETF | 0.35641 | 479.5 | 0.35 |
| Principal Healthcare Innovators ETF | 0.35641 | -3.92 | 0.35 |
| iShares Morningstar Small-Cap Value ETF | 0.06269 | 175.74 | 0.06 |
| iShares Morningstar Small-Cap ETF | 0.05548 | 301.34 | 0.25 |
| iShares Morningstar Small-Cap Growth ETF | 0.04907 | 570.49 | 0.06 |
| 0.18 | 304.63 | 0.21 |
|---|
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Dr. Romesh Subramanian Ph.D. | Co-Founder & Advisor | 565.17k | 1965 (60 years) |
| Dr. Oxana Beskrovnaya Ph.D. | Chief Scientific Officer | 631.08k | 1961 (64 years) |
| Ms. Amy Reilly | Senior VP and Head of Corporate Communications & Investor Relations | N/A | 1974 (51 year) |
| Ms. Debra Feldman | Chief Regulatory Affairs Officer | N/A | 1971 (54 years) |
| Mr. Richard William Scalzo M.B.A. | Senior VP and Head of Finance & Administration | N/A | 1986 (39 years) |
| Mr. Daniel Wilson | Senior VP & Head of Legal | N/A | 1972 (53 years) |
| Mr. John Najim M.B.A. | Chief Technical Officer | N/A | |
| Mr. John G. Cox M.B.A. | CEO, President & Director | 1963 (62 years) | |
| Ms. Lucia Celona | Chief Human Resource Officer | 1966 (59 years) | |
| Dr. Ashish Dugar M.B.A., Ph.D. | Chief Medical Affairs Officer |
About company
Address: United States, Waltham, 830 Winter Street - Open in google maps, Open in yandex maps
Website: https://www.dyne-tx.com
Website: https://www.dyne-tx.com
